Intrinsic Value

Supernus Pharmaceuticals, Inc. (SUPN)

$34.11

+0.37 (+1.10%)

Enterprise Value 3,945.57
Net Debt -33.53
Equity Value 3,979.09
Shares Outstanding 55.51
Equity Value Per Share 71.69



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt